| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From Cardiovascular Division (Y.H., Y.-S.C., Z.L., N.B., D.R., P.M.K.), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; Department of Cardiology (E.B., W.T.P.), Childrens Hospital Boston, Boston, Mass.
Correspondence to Peter M. Kang, MD, Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, SL-423C, Boston, MA 02215. E-mail pkang{at}bidmc.harvard.edu
Caspase-9 is a critical regulator of mitochondria-mediated apoptosis. We found that adult cardiac myocytes, but not nonmyocytes, have high caspase-9 expression, and exhibit relative resistance to caspase-9induced cell death. Thus, we hypothesized that cardiac myocytes possess factors that resist apoptosis. Through a yeast two-hybrid screening of adult human heart cDNA library, we identified HS-1 associated protein-1 (HAX-1), a 35-kD BH-domain containing protein localized to the mitochondria as one of the molecules that interacts with caspase-9. Recombinant HAX-1 protein inhibited caspase-9 processing in a dose-dependent manner in a cell-free caspase activation assay. Overexpression of HAX-1 in adult cardiac myocytes conferred 30% protection from apoptosis as compared with the control. Suppression of HAX-1 expression using siRNA-HAX-1 resulted in significant cell death in adult cardiac myocytes, suggesting the importance of HAX-1 in cardiac myocyte resistance to apoptotic stimulation. On apoptotic stimulation, some caspase-9 translocated to the mitochondria and co-localized with HAX-1, confirming the spatial proximity of caspase-9 and HAX-1. In summary, HAX-1 is a newly identified anti-apoptotic factor and its mechanism of action is through caspase-9 inhibition.
Key Words: apoptosis cardiac myocytes caspase HAX-1 mitochondria
Related Article:
Circ. Res. 2006 99: 336-338.
This article has been cited by other articles:
![]() |
K. Matsubara, K. Imai, S. Okada, M. Miki, N. Ishikawa, M. Tsumura, T. Kato, O. Ohara, S. Nonoyama, and M. Kobayashi Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency Haematologica, December 1, 2007; 92(12): e123 - e125. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xu, Y. Lu, Z. Pan, W. Chu, X. Luo, H. Lin, J. Xiao, H. Shan, Z. Wang, and B. Yang The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes J. Cell Sci., September 1, 2007; 120(17): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shaw and L. A. Kirshenbaum HAX-1 Represses Postmitochondrial Caspase-9 Activation and Cell Death During Hypoxia-Reoxygenation Circ. Res., August 18, 2006; 99(4): 336 - 338. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |